Cancer News and Research

Latest Cancer News and Research

TomoTherapy to discuss the uses of CT scanner-based device at the 10th Biennial ESTRO Conference

TomoTherapy Incorporated announced today that there will be more than 40 presentations at the 10th Biennial ESTRO Conference on Physics and Radiation Technology for Clinical Radiotherapy that explore use of the TomoTherapy treatment system. The TomoTherapy system -- a versatile, CT scanner-based device that integrates image guidance for increased treatment accuracy and helical radiation therapy delivery for enhanced tumor targeting -- is helping cancer centers advance patient care around the world.

28 Aug 2009

$11.5 million grant to Mayo Clinic Cancer Center to translate research into treatments for women with ovarian cancer

Investigators at the Mayo Clinic Cancer Center have received a five-year, $11.5 million grant to translate research into treatments for women with ovarian cancer.

28 Aug 2009

Novel methodology developed to extract microRNAs from cancer tissues

Researchers led by Dr. Soheil Dadras at the Stanford University Medical Center have developed a novel methodology to extract microRNAs from cancer tissues. The related report by Ma et al, "Profiling and discovery of novel miRNAs from formalin-fixed paraffin-embedded melanoma and nodal specimens," appears in the September 2009 issue of the Journal of Molecular Diagnostics.

28 Aug 2009

Kingston General Hospital adopts Sentinelle Medical's new breast imaging system through HTAIP

Dr. Morris (Mickey) Milner, President and CEO of The Health Technology Exchange (HTX), announced the successful adoption of Sentinelle Medical's new breast imaging system by Kingston General Hospital (KGH), through the HTX's Health Technology Assessment and Implementation Program (HTAIP), a program funded by the Ontario Ministry of Research and Innovation.

28 Aug 2009

Gen-Probe commences clinical study to secure U.S. approval of the PROGENSA PCA3 assay

DiagnoCure Inc. (TSX: CUR) announced that Gen-Probe, Inc. (NASDAQ: GPRO), its partner for the development and commercialization of the PCA3 prostate cancer test, has confirmed today the beginning of a U.S. clinical study intended to secure U.S. regulatory approval of the PROGENSA(R) PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.

28 Aug 2009

Champions Biotechnology reports higher year-on-year operating revenues for fiscal year 2009

Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2009. Full details of the Company's financial results are available in the Company's Form 10-K available at www.championsbiotechnology.com.

28 Aug 2009

Chk1 and Fbx6 play an important role for the regulation of response to chemotherapy

Cell cycle checkpoints act like molecular tripwires for damaged cells, forcing them to pause and take stock. Leave the tripwire in place for too long, though, and cancer cells will press on regardless, making them resistant to the lethal effects of certain types of chemotherapy, according to researchers at the Salk Institute for Biological Studies.

28 Aug 2009

Arno Therapeutics to commence Phase 1 clinical study of AR-12 in adult patients with lymphoma

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the dosing of the first patient in a Phase I clinical study of AR-12 (formerly OSU-03012) in adult patients with advanced or recurrent solid tumors or lymphoma.

28 Aug 2009

Scientists discover the vulnerability of old people to cancer and skin infections

Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have discovered why older people may be so vulnerable to cancer and infections in the skin. The team from UCL has shown in human volunteers that defective immunity in the skin is caused by an inability to mobilise essential defences that would otherwise recognise threats and clear them before irreparable damage is done.

28 Aug 2009

Fatostatin lowers the activity of genes associated with cholesterol synthesis

A small molecule earlier found to have both anti-fat and anti-cancer abilities works as a literal turnoff for fat-making genes, according to a new report in the August 28th issue of the journal Chemistry and Biology, a Cell Press journal.

27 Aug 2009

Health Canada issues marketing approval for NeuroVasx's cPAX Aneurysm Treatment System

NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.

27 Aug 2009

Study: Patients may face radioactive risk from imaging tests

"At least four million Americans under age 65 are exposed to high doses of radiation each year from medical imaging tests, according to a new study in The New England Journal of Medicine," The New York Times reports. And about ten percent of those patients "receive very high doses, more than the maximum annual exposure allowed for nuclear power plant employees or anyone else who works with radioactive material." The study was based on a survey of nearly one million patients insured by UnitedHealthcare.

27 Aug 2009

Resonant Medical's multi-anatomy Clarity System to be exhibited at ESTRO, Netherlands

Resonant Medical, an innovator in soft tissue planning, image-guidance and adaptive radiotherapy products, today announced that the Company will be exhibiting the next generation of its multi-anatomy Clarity System at the 10th Biennial Meeting of The European Society of Therapeutic Radiology and Oncologists (ESTRO), being held in Maastricht, Netherlands.

27 Aug 2009

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

Geron Corporation today provided additional comments on the recent clinical hold on its Spinal Cord Injury IND.

27 Aug 2009

First Edition: August 27, 2009

Today's news: Speculation begins regarding the impact Sen. Kennedy's death will have on the health reform debate and the Democrat's prospects for success.

27 Aug 2009

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

Three out of four medical groups of Resurrection Health Care Preferred (RHCP) have earned nine blue stars, a perfect score, in the 2009 Blue Star Report -- an annual ranking of doctors in medical groups from Blue Cross Blue Shield of Illinois.

27 Aug 2009

oBand uses the da Vinci Surgical System to perform the world's first robotic surgery in an outpatient surgical center

oBand Surgery Centers, the nation's leading bariatric network of outpatient surgical facilities owned and operated by nationally recognized Lap Band surgeons, has set a new 'first' in the use of robotics for outpatient surgery. oBand Director of Robotic Surgery S. Adam Ramin, M.D., an assistant professor at City of Hope National Medical Center, today announced they have performed the world's first, outpatient robotic surgery using the famed da Vinci® Surgical System. Dr. Ramin performed the innovative surgery in July in Los Angeles using Robotics to remove a patient's pelvic cyst.

27 Aug 2009

Clinical data added to ORENCIA labeling help treat patients with rheumatoid arthritis

Bristol-Myers Squibb Company announced today that clinical data added to the labeling for ORENCIA (abatacept) support use of ORENCIA for patients with moderate to severe rheumatoid arthritis of less than or equal to two years duration.

27 Aug 2009

Haber’s Electromolecular Propulsion technology offers high molecular separation speeds

Haber, Inc. (“Haber”), (OTC: HABE), a Delaware corporation headquartered in Arlington, Mass., with proprietary technologies in the separations sciences and environmentally friendly processing of gold bearing ores, announced today that it has formed a wholly owned subsidiary incorporated in Delaware called “EMP Diagnostics Inc.” (“EDI”). The business of the new company will focus on the application of Haber’s Electromolecular Propulsion technology (EMP). EMP is a separation technology that achieves unrivaled molecular separation speeds and has other unique capabilities not attainable with electrophoresis or liquid chromatography.

27 Aug 2009

Viral Genetics cautions investors and the public to rely only on its own releases and disclosures

Viral Genetics (Pink Sheets: VRAL), a biotechnology company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, is issuing this announcement in response to a series of press releases distributed by collegestock.com on August 25 and August 26, and an article published on Today's Financial News entitled "TFN Reader Grapevine: There's Something About Viral Genetics, Inc. (VRAL)," on August 25.

27 Aug 2009

Cancer News and Research

Latest Cancer News and Research

TomoTherapy to discuss the uses of CT scanner-based device at the 10th Biennial ESTRO Conference

$11.5 million grant to Mayo Clinic Cancer Center to translate research into treatments for women with ovarian cancer

Novel methodology developed to extract microRNAs from cancer tissues

Kingston General Hospital adopts Sentinelle Medical's new breast imaging system through HTAIP

Gen-Probe commences clinical study to secure U.S. approval of the PROGENSA PCA3 assay

Champions Biotechnology reports higher year-on-year operating revenues for fiscal year 2009

Chk1 and Fbx6 play an important role for the regulation of response to chemotherapy

Arno Therapeutics to commence Phase 1 clinical study of AR-12 in adult patients with lymphoma

Scientists discover the vulnerability of old people to cancer and skin infections

Fatostatin lowers the activity of genes associated with cholesterol synthesis

Health Canada issues marketing approval for NeuroVasx's cPAX Aneurysm Treatment System

Study: Patients may face radioactive risk from imaging tests

Resonant Medical's multi-anatomy Clarity System to be exhibited at ESTRO, Netherlands

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

First Edition: August 27, 2009

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

oBand uses the da Vinci Surgical System to perform the world's first robotic surgery in an outpatient surgical center

Clinical data added to ORENCIA labeling help treat patients with rheumatoid arthritis

Haber’s Electromolecular Propulsion technology offers high molecular separation speeds

Viral Genetics cautions investors and the public to rely only on its own releases and disclosures

Cancer Research - Second Edition eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in